Selected research
Industry Research
Pathology AI Software Industry Research Report 2026
Market perspective
The global Pathology AI Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pathology AI Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pathology AI Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pathology AI Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pathology AI Software include PathAI, Proscia, Aiforia, Deep Bio, Hologic, Dipath, iDeepwise, LBP and F.Q pathtech, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pathology AI Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pathology AI Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pathology AI Software Market by Company
PathAI
Proscia
Aiforia
Deep Bio
Hologic
Dipath
iDeepwise
LBP
F.Q pathtech
CellaVision
AIRA Matrix
Syntropy
Indica Labs
DoMore Diagnostics
Mindpeak
Evidium
Pathology AI Software Segment by Type
Cloud-Based
On-Premise
Pathology AI Software Segment by Application
Hospital
Diagnostic Centers
Laboratories & Research Institutes
Pathology AI Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology AI Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pathology AI Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology AI Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pathology AI Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based
- On-Premise
Applications
- Hospital
- Diagnostic Centers
- Laboratories & Research Institutes
Companies covered
- PathAI
- Proscia
- Aiforia
- Deep Bio
- Hologic
- Dipath
- iDeepwise
- LBP
- F.Q pathtech
- CellaVision
- AIRA Matrix
- Syntropy
- Indica Labs
- DoMore Diagnostics
- Mindpeak
- Evidium
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pathology AI Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-Based
- 2.2.3 On-Premise
- 2.3 Pathology AI Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Diagnostic Centers
- 2.3.4 Laboratories & Research Institutes
- 2.4 Assumptions and Limitations
3 Pathology AI Software Breakdown Data by Type
- 3.1 Global Pathology AI Software Historic Market Size by Type (2021-2026)
- 3.2 Global Pathology AI Software Forecasted Market Size by Type (2027-2032)
4 Pathology AI Software Breakdown Data by Application
- 4.1 Global Pathology AI Software Historic Market Size by Application (2021-2026)
- 4.2 Global Pathology AI Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pathology AI Software Market Perspective (2021-2032)
- 5.2 Global Pathology AI Software Growth Trends by Region
- 5.2.1 Global Pathology AI Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pathology AI Software Historic Market Size by Region (2021-2026)
- 5.2.3 Pathology AI Software Forecasted Market Size by Region (2027-2032)
- 5.3 Pathology AI Software Market Dynamics
- 5.3.1 Pathology AI Software Industry Trends
- 5.3.2 Pathology AI Software Market Drivers
- 5.3.3 Pathology AI Software Market Challenges
- 5.3.4 Pathology AI Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pathology AI Software Players by Revenue
- 6.1.1 Global Top Pathology AI Software Players by Revenue (2021-2026)
- 6.1.2 Global Pathology AI Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Pathology AI Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pathology AI Software Head Office and Area Served
- 6.4 Global Pathology AI Software Players, Product Type & Application
- 6.5 Global Pathology AI Software Manufacturers Established Date
- 6.6 Global Pathology AI Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pathology AI Software Market Size (2021-2032)
- 7.2 North America Pathology AI Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pathology AI Software Market Size by Country (2021-2026)
- 7.4 North America Pathology AI Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pathology AI Software Market Size (2021-2032)
- 8.2 Europe Pathology AI Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pathology AI Software Market Size by Country (2021-2026)
- 8.4 Europe Pathology AI Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pathology AI Software Market Size (2021-2032)
- 9.2 Asia-Pacific Pathology AI Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pathology AI Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pathology AI Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pathology AI Software Market Size (2021-2032)
- 10.2 South America Pathology AI Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pathology AI Software Market Size by Country (2021-2026)
- 10.4 South America Pathology AI Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pathology AI Software Market Size (2021-2032)
- 11.2 Middle East & Africa Pathology AI Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pathology AI Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pathology AI Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 PathAI
- 12.1.1 PathAI Company Information
- 12.1.2 PathAI Business Overview
- 12.1.3 PathAI Revenue in Pathology AI Software Business (2021-2026)
- 12.1.4 PathAI Pathology AI Software Product Portfolio
- 12.1.5 PathAI Recent Developments
- 12.2 Proscia
- 12.2.1 Proscia Company Information
- 12.2.2 Proscia Business Overview
- 12.2.3 Proscia Revenue in Pathology AI Software Business (2021-2026)
- 12.2.4 Proscia Pathology AI Software Product Portfolio
- 12.2.5 Proscia Recent Developments
- 12.3 Aiforia
- 12.3.1 Aiforia Company Information
- 12.3.2 Aiforia Business Overview
- 12.3.3 Aiforia Revenue in Pathology AI Software Business (2021-2026)
- 12.3.4 Aiforia Pathology AI Software Product Portfolio
- 12.3.5 Aiforia Recent Developments
- 12.4 Deep Bio
- 12.4.1 Deep Bio Company Information
- 12.4.2 Deep Bio Business Overview
- 12.4.3 Deep Bio Revenue in Pathology AI Software Business (2021-2026)
- 12.4.4 Deep Bio Pathology AI Software Product Portfolio
- 12.4.5 Deep Bio Recent Developments
- 12.5 Hologic
- 12.5.1 Hologic Company Information
- 12.5.2 Hologic Business Overview
- 12.5.3 Hologic Revenue in Pathology AI Software Business (2021-2026)
- 12.5.4 Hologic Pathology AI Software Product Portfolio
- 12.5.5 Hologic Recent Developments
- 12.6 Dipath
- 12.6.1 Dipath Company Information
- 12.6.2 Dipath Business Overview
- 12.6.3 Dipath Revenue in Pathology AI Software Business (2021-2026)
- 12.6.4 Dipath Pathology AI Software Product Portfolio
- 12.6.5 Dipath Recent Developments
- 12.7 iDeepwise
- 12.7.1 iDeepwise Company Information
- 12.7.2 iDeepwise Business Overview
- 12.7.3 iDeepwise Revenue in Pathology AI Software Business (2021-2026)
- 12.7.4 iDeepwise Pathology AI Software Product Portfolio
- 12.7.5 iDeepwise Recent Developments
- 12.8 LBP
- 12.8.1 LBP Company Information
- 12.8.2 LBP Business Overview
- 12.8.3 LBP Revenue in Pathology AI Software Business (2021-2026)
- 12.8.4 LBP Pathology AI Software Product Portfolio
- 12.8.5 LBP Recent Developments
- 12.9 F.Q pathtech
- 12.9.1 F.Q pathtech Company Information
- 12.9.2 F.Q pathtech Business Overview
- 12.9.3 F.Q pathtech Revenue in Pathology AI Software Business (2021-2026)
- 12.9.4 F.Q pathtech Pathology AI Software Product Portfolio
- 12.9.5 F.Q pathtech Recent Developments
- 12.10 CellaVision
- 12.10.1 CellaVision Company Information
- 12.10.2 CellaVision Business Overview
- 12.10.3 CellaVision Revenue in Pathology AI Software Business (2021-2026)
- 12.10.4 CellaVision Pathology AI Software Product Portfolio
- 12.10.5 CellaVision Recent Developments
- 12.11 AIRA Matrix
- 12.11.1 AIRA Matrix Company Information
- 12.11.2 AIRA Matrix Business Overview
- 12.11.3 AIRA Matrix Revenue in Pathology AI Software Business (2021-2026)
- 12.11.4 AIRA Matrix Pathology AI Software Product Portfolio
- 12.11.5 AIRA Matrix Recent Developments
- 12.12 Syntropy
- 12.12.1 Syntropy Company Information
- 12.12.2 Syntropy Business Overview
- 12.12.3 Syntropy Revenue in Pathology AI Software Business (2021-2026)
- 12.12.4 Syntropy Pathology AI Software Product Portfolio
- 12.12.5 Syntropy Recent Developments
- 12.13 Indica Labs
- 12.13.1 Indica Labs Company Information
- 12.13.2 Indica Labs Business Overview
- 12.13.3 Indica Labs Revenue in Pathology AI Software Business (2021-2026)
- 12.13.4 Indica Labs Pathology AI Software Product Portfolio
- 12.13.5 Indica Labs Recent Developments
- 12.14 DoMore Diagnostics
- 12.14.1 DoMore Diagnostics Company Information
- 12.14.2 DoMore Diagnostics Business Overview
- 12.14.3 DoMore Diagnostics Revenue in Pathology AI Software Business (2021-2026)
- 12.14.4 DoMore Diagnostics Pathology AI Software Product Portfolio
- 12.14.5 DoMore Diagnostics Recent Developments
- 12.15 Mindpeak
- 12.15.1 Mindpeak Company Information
- 12.15.2 Mindpeak Business Overview
- 12.15.3 Mindpeak Revenue in Pathology AI Software Business (2021-2026)
- 12.15.4 Mindpeak Pathology AI Software Product Portfolio
- 12.15.5 Mindpeak Recent Developments
- 12.16 Evidium
- 12.16.1 Evidium Company Information
- 12.16.2 Evidium Business Overview
- 12.16.3 Evidium Revenue in Pathology AI Software Business (2021-2026)
- 12.16.4 Evidium Pathology AI Software Product Portfolio
- 12.16.5 Evidium Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst